Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways

European Respiratory Journal

Volumn 22, Issue 3, 2003, Pages 457-461

  Ichinose, Masakazu ^a   Sugiura, H ^b   Yamagata, S ^b   Koarai, A ^b   Tomaki, M ^b   Ogawa, H ^b   Komaki, Y ^b   Barnes, P J ^c   Shirato, K ^b   Hattori, T ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Exhaled nitric oxide; Nitrotyrosine

Indexed keywords

3 NITROTYROSINE; ALLOPURINOL; BRONCHODILATING AGENT; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; SUPEROXIDE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ADULT; AGED; AIRWAY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXHALATION; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; SPUTUM; SYNTHESIS;

AGED; ALLOPURINOL; BREATH TESTS; ENZYME INHIBITORS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE NITROGEN SPECIES; SPUTUM; TYROSINE; XANTHINE OXIDASE;

EID: 10744220724     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00052002     Document Type: Article

References (29)

1. Murray CJL, Lopez AD. Evidence-based health policy: lessons from the global burden of disease study. Science 1996; 274: 740-743.
2. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
3. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256-1276.
4. Barnes PJ. New therapy for chronic obstructive pulmonary disease. Thorax 1998; 53: 137-147.
5. Turato G, Di Stefano A, Maestrelli P, et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995; 152: 1262-1267.
6. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055-1060.
7. Pinamonti S, Muzzoli M, Chicca MC, et al. Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free Radic Biol Med 1996; 21: 147-155.
8. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 341-357.
9. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
10. Beckman JS, Beckman TM, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
11. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9: 836-844.
12. Sugiura H, Ichinose M, Oyake T, et al. Role of peroxynitrite in airway microvascular hyperpermeability during late allergic phase in guinea pigs. Am J Respir Crit Care Med 1999; 160: 663-671.
13. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increased reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000; 162: 701-706.
14. Silkoff PE, McClean PA, Slutsky AS, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997; 155: 260-267.
15. Tomaki M, Ichinose M, Miura M, et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995; 151: 613-617.
16. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
17. Kay AB, Austen KF. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol 1971; 107: 899-902.
18. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998; 12: 929-937.
19. - generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 1990; 85: 739-745.
20. van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract. Am J Respir Crit Care Med 1999; 160: 1-9.
21. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite. Am J Physiol 1996; 271: C1424-C1437.
22. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide disumutase. Arch Biochem Biophys 1992; 298: 431-437.
23. Beckman JS, Ischiropoulos H, Zhu L, et al. Kinetics of superoxide disumutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys 1992; 298: 438-445.
24. Okamoto T, Akaike T, Nagano T, et al. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys 1997; 342: 261-274.
25. Pinamonti S, Leis M, Barbieri A, et al. Detection of xanthine oxidase activity products by EPR and HPLC in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free Radic Biol Med 1988; 25: 771-779.
26. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393-397.
27. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
28. Heunks LMA, Vina J, van Herwaaden CLA, Folgering HTM, Gimeno A, Dekhuijzen PNR. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999; 277: R1697-R1704.
29. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-280.